Global Hemophilia Gene Therapy Supply, Demand and Key Producers, 2024-2030

Page: 103

Published Date: 09 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Hemophilia Gene Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.

Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.

This report studies the global Hemophilia Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemophilia Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemophilia Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hemophilia Gene Therapy total market, 2019-2030, (USD Million)
Global Hemophilia Gene Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Hemophilia Gene Therapy total market, key domestic companies and share, (USD Million)
Global Hemophilia Gene Therapy revenue by player and market share 2019-2024, (USD Million)
Global Hemophilia Gene Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Hemophilia Gene Therapy total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Hemophilia Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, BioMarin, uniQure and Freeline Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemophilia Gene Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hemophilia Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hemophilia Gene Therapy Market, Segmentation by Type
Hemophilia A
Hemophilia B

Global Hemophilia Gene Therapy Market, Segmentation by Application
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy

Companies Profiled:
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics

Key Questions Answered
1. How big is the global Hemophilia Gene Therapy market?
2. What is the demand of the global Hemophilia Gene Therapy market?
3. What is the year over year growth of the global Hemophilia Gene Therapy market?
4. What is the total value of the global Hemophilia Gene Therapy market?
5. Who are the major players in the global Hemophilia Gene Therapy market?

Table of Contents

1 Supply Summary
    1.1 Hemophilia Gene Therapy Introduction
    1.2 World Hemophilia Gene Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Hemophilia Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Hemophilia Gene Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.3 China Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.4 Europe Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.5 Japan Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.6 South Korea Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.7 ASEAN Hemophilia Gene Therapy Market Size (2019-2030)
        1.3.8 India Hemophilia Gene Therapy Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hemophilia Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hemophilia Gene Therapy Major Market Trends

2 Demand Summary
    2.1 World Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.2 World Hemophilia Gene Therapy Consumption Value by Region
        2.2.1 World Hemophilia Gene Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Hemophilia Gene Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.4 China Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.5 Europe Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.6 Japan Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.7 South Korea Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.8 ASEAN Hemophilia Gene Therapy Consumption Value (2019-2030)
    2.9 India Hemophilia Gene Therapy Consumption Value (2019-2030)

3 World Hemophilia Gene Therapy Companies Competitive Analysis
    3.1 World Hemophilia Gene Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Hemophilia Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Hemophilia Gene Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Hemophilia Gene Therapy in 2023
    3.3 Hemophilia Gene Therapy Company Evaluation Quadrant
    3.4 Hemophilia Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Hemophilia Gene Therapy Market: Region Footprint
        3.4.2 Hemophilia Gene Therapy Market: Company Product Type Footprint
        3.4.3 Hemophilia Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Hemophilia Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Hemophilia Gene Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Hemophilia Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Hemophilia Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Hemophilia Gene Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hemophilia Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Hemophilia Gene Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Hemophilia Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Hemophilia Gene Therapy Revenue, (2019-2024)
    4.4 China Based Companies Hemophilia Gene Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Hemophilia Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Hemophilia Gene Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Hemophilia Gene Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Hemophilia Gene Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Hemophilia Gene Therapy Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Hemophilia Gene Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Hemophilia A
        5.2.2 Hemophilia B
    5.3 Market Segment by Type
        5.3.1 World Hemophilia Gene Therapy Market Size by Type (2019-2024)
        5.3.2 World Hemophilia Gene Therapy Market Size by Type (2025-2030)
        5.3.3 World Hemophilia Gene Therapy Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hemophilia Gene Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hemophilia A Gene Therapy
        6.2.2 Hemophilia B Gene Therapy
    6.3 Market Segment by Application
        6.3.1 World Hemophilia Gene Therapy Market Size by Application (2019-2024)
        6.3.2 World Hemophilia Gene Therapy Market Size by Application (2025-2030)
        6.3.3 World Hemophilia Gene Therapy Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Spark Therapeutics
        7.1.1 Spark Therapeutics Details
        7.1.2 Spark Therapeutics Major Business
        7.1.3 Spark Therapeutics Hemophilia Gene Therapy Product and Services
        7.1.4 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Spark Therapeutics Recent Developments/Updates
        7.1.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.2 Ultragenyx
        7.2.1 Ultragenyx Details
        7.2.2 Ultragenyx Major Business
        7.2.3 Ultragenyx Hemophilia Gene Therapy Product and Services
        7.2.4 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Ultragenyx Recent Developments/Updates
        7.2.6 Ultragenyx Competitive Strengths & Weaknesses
    7.3 Shire PLC
        7.3.1 Shire PLC Details
        7.3.2 Shire PLC Major Business
        7.3.3 Shire PLC Hemophilia Gene Therapy Product and Services
        7.3.4 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Shire PLC Recent Developments/Updates
        7.3.6 Shire PLC Competitive Strengths & Weaknesses
    7.4 Sangamo Therapeutics
        7.4.1 Sangamo Therapeutics Details
        7.4.2 Sangamo Therapeutics Major Business
        7.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Product and Services
        7.4.4 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Sangamo Therapeutics Recent Developments/Updates
        7.4.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
    7.5 Bioverativ
        7.5.1 Bioverativ Details
        7.5.2 Bioverativ Major Business
        7.5.3 Bioverativ Hemophilia Gene Therapy Product and Services
        7.5.4 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Bioverativ Recent Developments/Updates
        7.5.6 Bioverativ Competitive Strengths & Weaknesses
    7.6 BioMarin
        7.6.1 BioMarin Details
        7.6.2 BioMarin Major Business
        7.6.3 BioMarin Hemophilia Gene Therapy Product and Services
        7.6.4 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 BioMarin Recent Developments/Updates
        7.6.6 BioMarin Competitive Strengths & Weaknesses
    7.7 uniQure
        7.7.1 uniQure Details
        7.7.2 uniQure Major Business
        7.7.3 uniQure Hemophilia Gene Therapy Product and Services
        7.7.4 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 uniQure Recent Developments/Updates
        7.7.6 uniQure Competitive Strengths & Weaknesses
    7.8 Freeline Therapeutics
        7.8.1 Freeline Therapeutics Details
        7.8.2 Freeline Therapeutics Major Business
        7.8.3 Freeline Therapeutics Hemophilia Gene Therapy Product and Services
        7.8.4 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Freeline Therapeutics Recent Developments/Updates
        7.8.6 Freeline Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hemophilia Gene Therapy Industry Chain
    8.2 Hemophilia Gene Therapy Upstream Analysis
    8.3 Hemophilia Gene Therapy Midstream Analysis
    8.4 Hemophilia Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hemophilia Gene Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Hemophilia Gene Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Hemophilia Gene Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Hemophilia Gene Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Hemophilia Gene Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Hemophilia Gene Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Hemophilia Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Hemophilia Gene Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Hemophilia Gene Therapy Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Hemophilia Gene Therapy Players in 2023
    Table 12. World Hemophilia Gene Therapy Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Hemophilia Gene Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Hemophilia Gene Therapy Player
    Table 15. Hemophilia Gene Therapy Market: Company Product Type Footprint
    Table 16. Hemophilia Gene Therapy Market: Company Product Application Footprint
    Table 17. Hemophilia Gene Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Hemophilia Gene Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Hemophilia Gene Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Hemophilia Gene Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Hemophilia Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Hemophilia Gene Therapy Revenue Market Share (2019-2024)
    Table 23. China Based Hemophilia Gene Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Hemophilia Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Hemophilia Gene Therapy Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Hemophilia Gene Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Hemophilia Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Hemophilia Gene Therapy Revenue Market Share (2019-2024)
    Table 29. World Hemophilia Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Hemophilia Gene Therapy Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Hemophilia Gene Therapy Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Hemophilia Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Hemophilia Gene Therapy Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Hemophilia Gene Therapy Market Size by Application (2025-2030) & (USD Million)
    Table 35. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 36. Spark Therapeutics Major Business
    Table 37. Spark Therapeutics Hemophilia Gene Therapy Product and Services
    Table 38. Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Spark Therapeutics Recent Developments/Updates
    Table 40. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 41. Ultragenyx Basic Information, Area Served and Competitors
    Table 42. Ultragenyx Major Business
    Table 43. Ultragenyx Hemophilia Gene Therapy Product and Services
    Table 44. Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Ultragenyx Recent Developments/Updates
    Table 46. Ultragenyx Competitive Strengths & Weaknesses
    Table 47. Shire PLC Basic Information, Area Served and Competitors
    Table 48. Shire PLC Major Business
    Table 49. Shire PLC Hemophilia Gene Therapy Product and Services
    Table 50. Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Shire PLC Recent Developments/Updates
    Table 52. Shire PLC Competitive Strengths & Weaknesses
    Table 53. Sangamo Therapeutics Basic Information, Area Served and Competitors
    Table 54. Sangamo Therapeutics Major Business
    Table 55. Sangamo Therapeutics Hemophilia Gene Therapy Product and Services
    Table 56. Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Sangamo Therapeutics Recent Developments/Updates
    Table 58. Sangamo Therapeutics Competitive Strengths & Weaknesses
    Table 59. Bioverativ Basic Information, Area Served and Competitors
    Table 60. Bioverativ Major Business
    Table 61. Bioverativ Hemophilia Gene Therapy Product and Services
    Table 62. Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Bioverativ Recent Developments/Updates
    Table 64. Bioverativ Competitive Strengths & Weaknesses
    Table 65. BioMarin Basic Information, Area Served and Competitors
    Table 66. BioMarin Major Business
    Table 67. BioMarin Hemophilia Gene Therapy Product and Services
    Table 68. BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. BioMarin Recent Developments/Updates
    Table 70. BioMarin Competitive Strengths & Weaknesses
    Table 71. uniQure Basic Information, Area Served and Competitors
    Table 72. uniQure Major Business
    Table 73. uniQure Hemophilia Gene Therapy Product and Services
    Table 74. uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. uniQure Recent Developments/Updates
    Table 76. Freeline Therapeutics Basic Information, Area Served and Competitors
    Table 77. Freeline Therapeutics Major Business
    Table 78. Freeline Therapeutics Hemophilia Gene Therapy Product and Services
    Table 79. Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 80. Global Key Players of Hemophilia Gene Therapy Upstream (Raw Materials)
    Table 81. Hemophilia Gene Therapy Typical Customers
List of Figure
    Figure 1. Hemophilia Gene Therapy Picture
    Figure 2. World Hemophilia Gene Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Hemophilia Gene Therapy Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Hemophilia Gene Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Hemophilia Gene Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Hemophilia Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 13. Hemophilia Gene Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Hemophilia Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Hemophilia Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Hemophilia Gene Therapy by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Hemophilia Gene Therapy Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Hemophilia Gene Therapy Markets in 2023
    Figure 27. United States VS China: Hemophilia Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Hemophilia Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Hemophilia Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Hemophilia Gene Therapy Market Size Market Share by Type in 2023
    Figure 31. Hemophilia A
    Figure 32. Hemophilia B
    Figure 33. World Hemophilia Gene Therapy Market Size Market Share by Type (2019-2030)
    Figure 34. World Hemophilia Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Hemophilia Gene Therapy Market Size Market Share by Application in 2023
    Figure 36. Hemophilia A Gene Therapy
    Figure 37. Hemophilia B Gene Therapy
    Figure 38. Hemophilia Gene Therapy Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics

Related Reports

Global Hemophilia Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Hemophilia Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Hemophilia Gene Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>